# Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

> **NCT00505934** · PHASE2 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 19 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00505934
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505934, "Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00505934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*